Filament Health (NEOE:FH) Change In Inventory : C$0.00 Mil (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Filament Health Change In Inventory?

Filament Health's change in inventory for the quarter that ended in Sep. 2024 was C$0.00 Mil. It means Filament Health's inventory stayed the same from Jun. 2024 to Sep. 2024 .

Filament Health's change in inventory for the fiscal year that ended in Dec. 2023 was C$0.00 Mil. It means Filament Health's inventory stayed the same from Dec. 2022 to Dec. 2023 .

Filament Health's Total Inventories for the quarter that ended in Sep. 2024 was C$0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Filament Health's Inventory-to-Revenue for the quarter that ended in Sep. 2024 was 0.00.

Filament Health Change In Inventory Historical Data

The historical data trend for Filament Health's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Filament Health Change In Inventory Chart

Filament Health Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Filament Health Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Inventory	Get a 7-Day Free Trial											-	-	-	-	-

Filament Health Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Filament Health (NEOE:FH) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Filament Health's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	0	*	365 / 4
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Filament Health's Inventory Turnover for the quarter that ended in Sep. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Filament Health's Inventory to Revenue for the quarter that ended in Sep. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0.019
	=	0.00

Filament Health Change In Inventory Related Terms

Thank you for viewing the detailed overview of Filament Health's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Filament Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Filament Health Corp (NEOE:FH) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

FLHLF:USA 7QS:Germany

Address

4475 Wayburne Drive, Unit 210, Burnaby, BC, CAN, V5G 4X4

Website

https://www.filament.health

Filament Health Corp is a natural psychedelic drug development company. Its mission is to see safe, approved, natural psychedelics in the hands of everyone who needs them as soon as possible. The group engages in natural extraction technology commercialization, utilizing its intellectual property portfolio, in-house GMP facility, and Health Canada psilocybin Dealer's License.

Executives

Benjamin Lightburn	Director, Senior Officer
Thomas Kineshanko	10% Security Holder
Warren Duncan	Senior Officer

Filament Health Headlines

No Headlines